Mutia Nur Muslimah

Ms. Mutia Nur Muslimah


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Polymers
Verified
Journal Article
Open access
PDF file
ABArif Budiman
Arif Budiman
AHAnnisa Luthfiyah Handini
Annisa Luthfiyah Handini
MMMutia Nur Muslimah
Mutia Nur Muslimah
NNNeng Vera Nurani
Neng Vera Nurani
ELEli Laelasari
Eli Laelasari
Diah Lia AulifaDiah Lia Aulifa
Diah Lia Aulifa
Cancer treatment has improved over the past decades, but a major challenge lies in drug formulation, specifically for oral administration. Most anticancer drugs have poor water solubility which can affect their bioavailability. This causes suboptimal pharmacokinetic performance, resulting in limited efficacy and safety when administered orally. As a result, it is essential to develop a strategy to modify the solubility of anticancer drugs in oral formulations to improve their efficacy and safety. A promising approach that can be implemented is amorphous solid dispersion (ASD) which can enhance the aqueous solubility and bioavailability of poorly water-soluble drugs. The addition of a polymer can cause stability in the formulations and maintain a high supersaturation in bulk medium. Therefore, this study aimed to summarize and elucidate the mechanisms and impact of an amorphous solid dispersion system on cancer therapy. To gather relevant information, a comprehensive search was conducted using keywords such as “anticancer drug” and “amorphous solid dispersion” in the PubMed, Scopus, and Google Scholar databases. The review provides an overview and discussion of the issues related to the ASD system used to improve the bioavailability of anticancer drugs based on molecular pharmaceutics. A thorough understanding of anticancer drugs in this system at a molecular level is imperative for the rational design of the products.